Previous studies indicate that the modification of adrenergic neurotransmission in median raphe nucleus (MRN) enhances or removes an inhibitory influence on food intake, possibly serotonergic, due to a presence of serotonin-producing neurons in that nucleus. Therefore, the aim of this study is evaluated whether the activity of neurons in the MRN and dorsal raphe nucleus (DRN) are affected by intracerebroventricular injection of adrenaline (AD) in free-feeding rats. Male Wistar rats with guide cannulae chronically implanted in the lateral ventricle were injected with AD followed by evaluation of ingestive behavioral parameters. Behavior was monitored and the amount of food ingested was assessed. The highest dose (20 nmol) of AD was the most effective dose in increasing food intake. Subsequently, AD 20 nmol was injected to study neuronal activity indicated by the presence of Fos protein and its co-localization with serotonergic neurons in the MRN and DRN of naive rats with or without access to food during the recording of behavior. The administration of AD 20 nmol increased Fos expression and double labeling with serotonergic neurons in the DRN in rats with access to food, but not in animals without access. No statistically significant changes in Fos expression were observed in the MRN in any of the experimental conditions tested. These results suggest that DRN serotonergic and non-serotonergic neurons are activated by post-prandial signals. In contrast, the absence of Fos expression in the MRN suggests that this nucleus does not participate in the circuit involved in the control of post-prandial satiety.
Introduction
The dorsal raphe nucleus (DRN) and the median raphe nucleus (MRN) give rise to almost all serotonergic projections to forebrain structures such as the hippocampus, accumbens nucleus and hypothalamic nuclei (Azmitia and Segal, 1978; Lechin et al., 2006; Moore et al., 1978; Vertes and Linley, 2007) . Serotonergic neurons in the DRN and MRN are under the regulatory influence of many neurotransmitters, such as noradrenaline (NA), glutamate, and c-aminobutyric acid (GABA; Adell et al., 2002; Wirtshafter, 2001) . The locus coeruleus is the main source of NA in the central nervous system and both MRN and DRN receive noradrenergic innervation (Adell et al., 2002) . Moreover, studies indicate the presence of relatively high levels of a1 (Day et al., 1997) and a2-adrenoceptors (Rosin et al., 1993; Talley et al., 1996; Unnerstall et al., 1985) in both the MRN and DRN.
Previous studies in our laboratory suggest that adrenaline (AD) injected into the MRN decreases food intake in food-deprived rats (Maidel et al., 2007) but increases food intake in satiated rats (dos Santos et al., 2009 ). These AD effects on food intake were attributed to differential activation of pre-synaptic and post-synaptic a-adrenoceptors that is dependent on the nutritional state of the animal. Moreover, microdialysis studies demonstrated that administration of an a1 adrenoceptor agonist can increase the release of 5-HT in the MRN, while an a1 adrenoceptor antagonist suppressed release (Adell and Artigas, 1999) . Injection of clonidine, a selective a2 agonist, into the MRN of free-feeding rats caused a hyperphagic response which can be compared to the response induced by AD (Mansur et al., 2010) . Whereas, injection of the a1 agonist phenylephrine, did not affect ingestive behavior (Mansur et al., 2011b contrast, injection of prazosin, an a1 antagonist, increases food intake in free-feeding rats (Mansur et al., 2011a) and, more specifically, a1 A and a1 D antagonists have been demonstrated to induce hyperphagia in free-feeding rats (da Silva et al., 2014) . However, the injection of the a1 agonist phenylephrine, has also been reported to decrease food intake in food-deprived rats and in this case treatment with clonidine had no effect on feeding behavior (Ribas et al., 2012) . Thus, it is suggested that, in food-deprived rats, AD acts on a1 adrenoceptors, possibly in serotonergic neurons, causing release of 5-HT (Adell and Artigas, 1999) and inhibition of food intake (Levone et al., 2015) . However, in free-feeding rats, our hypothesis is that there is a basal and tonic activation of serotonergic neurons and the activation of a2 adrenoceptors removes this inhibitory tone, which increases food intake (dos Santos et al., 2009) .
Similar to the MRN, electrophysiological studies demonstrate that activation of a1 receptors increases the firing rate of serotonergic neurons in the DRN (Baraban and Aghajanian, 1980; Marwaha and Aghajanian, 1982; Vandermaelen and Aghajanian, 1983) . Conversely, activation of the a2 receptor decreases the firing rate of serotoninergic DRN neurons (Haddjeri et al., 1996; Svenson et al., 1975) . In addition, a1 antagonists decrease the release of 5-HT in projection areas (Bortolozzi and Artigas, 2003) , while a2 agonists inhibit the synthesis, metabolism and release of 5-HT in the DRN (Bortolozzi and Artigas, 2003; Clement et al., 1992; Yoshioka et al., 1992) . However, there is a paucity of evidence showing how adrenergic receptors, in the DRN, control food intake. Therefore, this study aims to evaluate how intracerebroventricular (ICV) injection of AD in free-feeding rats changes the activity of DRN and MRN neurons. Furthermore, double labeling immunohistochemistry was carried out in order to determine the chemical signature of Fos positive cells. In addition, hypothalamic neuronal activity was also analyzed.
Results
2.1. Experiment 1: drug dose effects of AD on ingestive and noningestive behaviors in free-feeding rats
The AD ICV injection of 6 and 20 nmol doses in free-feeding rats increased food intake [F (4, 34) = 55.33, p < .01] when compared with the control group (vehicle injection; Fig. 1 (Table 1) . The grooming duration reduced with the 6 and 20 nmol doses and the frequency with only the 20 nmol dose of AD (Table 1) . The other doses of AD did not affect the ingestive behavior observed (Fig. 1) . There was no water intake in animals treated with AD or vehicle or additional alterations in other non-ingestive behaviors (Table 1) .
Experiments 2 and 3:
Fos expression and its co-localization with serotonergic neurons in satiated rats with or without access to food during the experimental recording
The two-way ANOVA tests indicated that the number of Fos + [F (1, 13) = 9.34, p = .01] and double-labeled Fos+/5-HT + cells [F (1, 13) = 24.16, p < .01] in the DRN was affected by the ICV AD injection. In addition, there was a significant interaction between the treatment and the food availability in the number of doublelabeled Fos+/5-HT + cells [F (1, 13) = 16.72, p < .01] . Regarding that, the ICV injection of AD 20 nmol increased the number of Fos+ and Fos+/5-HT + cells in the DRN of rats with access to food (AF group; Fig. 2 ), compared to vehicle injected rats. However, AD injection caused no change in the number of Fos+ and Fos+/5-HT + cells in the DRN of satiated rats without access to food (WAF group; Fig. 2 ). In contrast, no statistically significant changes were found in Fos expression or double labeling in the MRN of AF and WAF groups (Fig. 3) . The mean number of 5-HT + cells per section in the different conditions for DRN and MRN were similar, suggesting that the sampling of these cells was not biased in any of the experimental conditions (Tables 2 and 3 ). The percentage of Fos+/5-HT + cells from total 5-HT immunoreactive cells in the DRN was about 6% in the AF group ( Table 2) .
The induction of Fos expression by icv injection of AD was also assessed in the hypothalamus. (Fig. 4) , while VMH did not present changes in Fos expression (Fig. 5) . The AF group presented a higher number of Fos + cells in VMH when compared to the WAF group after injection of AD 20 nmol (Fig. 5) . The LHA and ARC showed no statistically significant changes in Fos expression in both AF and WAF groups (Table 4) .
2.3. Experiment 2 and 3: effects of AD on ingestive and non-ingestive behaviors in satiated rats with or without access to food during the experimental recording
The feeding behavior in AF group was similar to those found in experiment 1 (data not shown). The two-way ANOVA tests indicated that the duration of grooming [F (1, 10) (Table 5 ). The WAF group presented an increase in duration of locomotion and in non-locomotor exploration when compared to all groups of AF animals (Table 5 ). However, the vehicle group of WAF animals showed a decrease in duration of non-locomotor exploration when compared to vehicle group of AF animals. The rearing behavior showed no statistically significant changes in AF and WAF groups (Table 5) .
Discussion
The present study demonstrated that ICV administration of AD increased food intake in satiated rats. These data are in accordance with previous studies showing that central administration of NA or AD in brain ventricles or directly in certain hypothalamic nuclei strongly stimulates food intake in several mammalian species and in different nutritional conditions (Antunes-Rodrigues and McCann, 1970; Booth, 1968; Leibowitz, 1978 Leibowitz, , 1984 Levine et al., 1991) .
Although AD was injected into the lateral ventricle, it could have reached the DRN through diffusion in the cerebrospinal fluid. However, the increased number of Fos+ and Fos+/5-HT + cells in the DRN of animals of AF group and the absence of changes in neuronal activity in animals of WAF group after ICV AD injection, suggests that DRN serotonergic and non-serotonergic neurons are activated by post-prandial signals and not by AD itself. Therefore, the direct activation of adrenergic receptors in the DRN is probably not responsible for causing the hyperphagic behavior observed in AD-injected rats. Studies comparing animals with free food access with fasted animals or submitted to a food restriction showed that the number of Fos-immunoreactive neurons increased in the DRN after food intake (Takase and Nogueira, 2008; Wu et al., 2014) . A meal can trigger short-term satiety signals from the periphery, which can be conveyed to the central nervous system via the vagus nerve to the nucleus of the solitary tract (NTS; Smith, 1996) . NTS neurons then send this information directly to hypothalamic nuclei, or indirectly to the cortex through brainstem structures like the locus coeruleus and raphe nuclei (Berthoud, 2002; Schwartz et al., 2000) . In this case, short-term satiety signals may be operating on the DRN nucleus, modifying neuronal activity and contributing to the end of the meal. The number of double-labeled in the DRN of animals with access to food is low when compared with the total of 5-HT immunoreactive cells (about 6%). However it appears to be a peculiarity for this nucleus, because studies have shown that even a strong stressor was able to activate at most only 7% of the estimated serotonin population in the DRN (Takase et al., 2004 (Takase et al., , 2005 . A single serotonergic neuron projects fiber to many different CNS structures and a low neuronal activation does not mean that these neurons are not responsive (Takase and Nogueira, 2008) . In the MRN, there was no difference in Fos expression in any of the experimental conditions, suggesting that this nucleus does not participate in the circuit involved in post-prandial satiety. It is necessary to point out that not all activated neurons actually express Fos protein (Herdegen and Leah, 1998) . In addition, the transcription of c-Fos can vary in different neurons and some may express low levels, which may not be detectable by immunohistochemical techniques (Zimmer et al., 1997) . Furthermore, data from our lab suggests that in free-feeding rats there is a basal tonic activation of MRN serotonergic neurons and an inhibitory influence that restrains food intake (Mansur et al., 2010 (Mansur et al., , 2011a . In basal conditions or tonically active neurons, Fos expression is absent or very low (Herrera and Robertson, 1996) . Consequently, this limitation may reduce our ability to detect Fos expression in the MRN. A robust innervation of the LHA by the MRN has been described in earlier studies (Vertes et al., 1999) . Moreover, the LHA is proposed to be an integration site for reward-related information and energy homeostasis (Hurley and Johnson, 2014) via neuronal connections with important nuclei related to motivational learning, such as the basolateral amygdala (Petrovich et al., 2002) . A recent study of our lab showed that prazosin injection into the MRN increased food intake in satiated rats and increased Fos expression in the basolateral amygdala and in orexin neurons of the LHA. These findings suggest that the MRN influence on feeding behavior might be mediated by the orexinergic system and the adrenergic circuit in the MRN may involve motivational, but not consummatory aspects of food intake (da Silva et al., 2017) . The increased number of Fos + cells in the PVN of animals of WAF group indicates that the feeding behavior effects induced by AD injection may be due to activation of adrenergic receptors within this nucleus. Previous studies have demonstrated the presence of a2 adrenoceptors in the PVN (Young and Kuhar, 1980; Leibowitz et al., 1982) . The stimulation of food intake by NA has been associated with these receptors (Leibowitz, 1978 (Leibowitz, , 1984 (Leibowitz, , 1988 . Furthermore, AD injection in the PVN significantly increased food intake in satiated rats . These similar effects to those following NA injection may be due to the presence of the converting enzyme of AD (phenylethanolamine-N-methyl transferase) in the nerve terminals of the PVN (Hokfelt et al., 1974 (Hokfelt et al., , 1988 .
The ICV AD injection also increased Fos + cells in the VMH, but this effect was observed only in rats with access to food. This result suggests that adrenergic receptors in this nucleus (Leibowitz, 1970) do not mediate the hyperphagic response induced by treatment with AD, but may respond to post-prandial signals. The presence of nutrients within the digestive tract stimulates the production and release of cholecystokinin (CCK). CCK receptors located in vagal nerve endings carry information to central nervous All data are expressed as mean ± S.E.M. Two-way ANOVA followed by Duncan's post hoc test (n = 5 per group). ARC: Arcuate Nucleus; LHA: Lateral Hypothalamic Area.
system structures (Liddle, 1994; Schwartz, 2000) . The VMH receives this peripheral information via afferents of the parabrachial nucleus and therefore, the changes in neuronal activity in the VMH could be a result of postprandial signals that contribute to the satiety process. A study comparing nonfasted animals with fasted and refeeding animals showed that refeeding increased Fos expression in the VMH, suggesting that these neurons primarily sense signals conveying energy intake, consistent with the notion that the VMH acts as a satiety center (Wu et al., 2014) . Additionally, a decrease in plasma glucose levels induces food intake, while hyperglycemia induces satiety (Oomura and Yoshimatsu, 1984) . A variety of neurons in the VMH are responsive to glucose and changes in plasma glucose levels can modify neuronal activity in this nucleus (Miki et al., 2001; Song and Routh, 2005) . These findings help to explain the lack of Fos in the VMH of rats without access to food during the experimental recording. Although the blood glucose levels have not been measured in this work, the increasing glucose associated with food intake induced by AD could be a possible metabolic signal activating VMH neurons. In satiated rats with access to food, the treatment with AD decreases the duration of resting and grooming behaviors. Postprandial signals induce the behavioral satiety sequence (Halford et al., 1998) which is characterized by an increase in grooming and resting after food intake. However, 30 min of behavioral recording may not be sufficient to observe the establishment of this sequence in animals treated with AD (Rodgers et al., 2010) . In rats without access to food, the ICV AD injection increased the duration and frequency of locomotion and non-locomotor exploration. It also reduced the duration of grooming and resting. These are behavioral changes typically observed in the search for food, in this case, caused by the adrenergic stimulation. Interestingly, there is a decrease in non-locomotor exploration between the controls groups of the WAF and AF animals. This difference was limited to this behavior, since the others non-ingestive behaviors remained unchanged. This result suggests that the ingestive e non ingestive behaviors status were similar between the control animals.
In conclusion, the present findings indicate that the hyperphagic effects in satiated rats after ICV AD injection may be due to activation of a-adrenergic receptors in the PVN. The experiments with and without access to food during the behavioral recording suggest that VMH, DRN serotonergic and nonserotonergic neurons are activated by post-prandial signals. In this case, the neural circuit receives short-term satiety signals to terminate the meal. In addition, the absence of Fos expression in the MRN in any of the experimental conditions in the current study suggests that this nucleus does not participate in the circuit involved in the control of post-prandial satiety.
Materials and methods

Animals and surgical procedures
Male Wistar rats were housed in groups of five in a temperature controlled (21 ± 2°C) room. Food and water were provided ad libitum on a 12/12 h light/dark cycle (lights on at 7:00 am). All experimental procedures in this study were performed in accordance with the ethical principles of animal experimentation, postulated by the Brazilian College of Animal Experimentation, and the trial protocol approved by the Ethics Committee on the Use of Animals of the Federal University of Santa Catarina (CEUA protocol: PP0075). All efforts were made to minimize the number of animals used and their pain and discomfort.
Animals weighing between 280 and 300 g underwent stereotaxic surgery for implantation of guide cannulae for subsequent drug microinjection into the lateral ventricle (LV). The animals were anesthetized with a mixture of xylazine (13 mg kg À1 ) and ketamine (87 mg kg À1 ) injected intraperitoneally. Then using stereotaxic apparatus (Insight Instruments, Ribeirão Preto, SP, BRA) a unilateral stainless steel guide cannula (30 G) was implanted within the LV according to the coordinates (anteroposterior: 0.8 mm, lateral: 1.5 mm and dorso-ventral: 3.0 mm) as described by Paxinos and Watson (2007) . The cannula was anchored to the skull with jeweler's screws and fixed with dental cement. The correct location of the cannula in the LV was verified through liquid column displacement (sterile saline).
Drugs and injections
The adrenergic agonist, adrenaline (AD; Sigma Chemical Co., St. Louis, MO, USA) was injected at doses of 0.2, 2, 6 and 20 nmol. A sterile solution of 0.9% NaCl was used as a vehicle for drug dilution (1 mL, VEH) or injected alone in the control groups. The AD doses were based on previously published studies of our research group. The injection of AD or vehicle was done with a 33 G needle (Injex, Surgical Industries LTD; Brazil) 2 mm longer than the guide cannula. The injection needle was inserted into the guide cannula and connected by a polyethylene tube (PE 10) of a micro syringe SGE Ò 5 lL. The solutions were administered during 60 s, followed by a further 60 s with the needle still inside the guide cannula for better diffusion of the solution.
Experimental procedures
After the surgery, the rats were housed individually with free access to food and water. After one week, the rats were habituated to the recording chamber for two consecutive days (30 min each day) before the experimental session. The experimental procedures were divided into three stages: 1) Evaluation of ingestive and noningestive behaviors after injection of 0.2, 2, 6 and 20 nmol doses of AD (n = 8 animals per group) injected into the LV (dose/response curve).
2) The most effective AD dose to increase food intake was injected into the LV of naive rats (n = 5 animals per group) to study neuronal activity by the identification of the presence of Fos protein. Co-localization studies were carried out to determine whether serotoninergic neurons in the MRN and DRN exhibited Fos labeling (access to food group -AF). 3) In order to evaluate the influence of post-prandial signals induced by food intake on Fos expression, an additional group of naive animals (n = 5 animals per group), treated with the most effective dose of AD, had no access to food during the behavioral recording (without access to food group -WAF). The immunohistochemistry in this experiment was performed as in experiment 2. With the exception of experiment 3, immediately after the microinjections, the animals were placed in a recording chamber containing granulated food and water. The digital recording of the session (30 min) was initiated with a web cam and at the end of the session the remaining food was collected and weighed. The difference between food or water weight at the beginning and at the end of the recording period was taken as the amount of food or water consumed. Video-recorded data were analyzed using EthoLog 2.2.5 software (Ottoni, 2000) . A researcher blinded to the experimental groups was designated to do all the behavioral analyzes. The variables analyzed for food intake and water intake were the amount of food or water consumed, the latency to start the behavior (in sec), the frequency (number of episodes that the animal exhibited the feeding behavior) and the total duration of behavior (in sec) during the 30 min of recording. For noningestive behaviors (food exploration, grooming, rearing, locomotion, non-locomotor exploration, immobility) we analyzed only the frequency and duration. The behavior categories were defined in previous studies by Halford et al. (1998) and are described in Table 6 . All experimental procedures were carried out from 13:30 pm to 17:00 pm (light cycle; lights off at 19:00 pm).
Histological analysis
For the dose/response curve at the end of each experiment the animals were anesthetized with urethane and then transcardially perfused with saline (0.9%) followed by formalin (10%). Immediately after the perfusion, 1 ul of Evans blue (10%) was injected using the injection system used for the administration of drugs to confirm the correct position of the guide cannula within the LV in all animal. Brains were removed from the animal's skull and Evans blue staining in the LV was observed macroscopically. Only data from rats in which the cannula was correctly placed into the LV were included in the study (approximately 95% of the animals).
Immunohistochemistry
Within a period of 90-120 min after injecting the drug or saline, the animals were anesthetized with a mixture of xylazine/ketamine injected intraperitoneally and perfused transcardially with 0.9% saline solution followed by formaldehyde solution (prepared from 4% paraformaldehyde). Brains were collected and post-fixed in the same fixative for 1-2 h and cryoprotected overnight at 4°C in 0.1 M PBS, containing 20% sucrose. Brains were cut (40 mm thick) in the transverse plane using a freezing microtome. Four series of tissue were collected in cryo-protectant solution and stored at À20°C. The correct positioning of the guide cannulae in all the animals used for the immunohistochemical reactions was confirmed by the histological analysis of brain sections (the presence of the cannula mark within the VL, approximately 96%). The Paxinos Atlas (2007) was used to evaluate the position of the injection sites.
For Fos immunohistochemistry, brain sections were washed in a 0.02 M potassium PBS, pH 7.4 solution (KBPS) for 30 min for the complete removal of antifreeze solution. Next, sections were incubated in a solution of KPBS containing 0.3% Triton X-100 (Sigma Chemical, St. Louis, MO, USA; KBPS-T solution) and 0.3% hydrogen peroxide for 30 min. The sections were washed again in KBPS and incubated for 60 min in KPBS-T containing 3% normal donkey serum to block non-specific antibody binding. Subsequently, sections were incubated overnight in anti-Fos primary antibody (1:20,000; Calbiochem, EMD Chemicals Inc., San Diego, USA) made in rabbit containing KPBS-T with azide and 3% donkey normal serum at room temperature. Sections were then incubated for 60 min with a solution containing a biotinylated anti-rabbit secondary antibody from donkey (1:1000; Jackson ImmunoResearch Inc., West Grove, PA, USA) made in KPBS-T. Then, the sections were incubated for 60 min with the avidin-biotin complex (ABC; 1:5000; Vector Laboratories, Inc. Burlingame, CA, USA) in KPBS. The sections were then subjected to a reaction using 0.1 M acetate buffer, diaminobenzidine (DAB; Sigma Chemical, St. Louis, MO, USA), 0.5% nickel sulfate and 0.01% hydrogen peroxide.
For double staining, the reaction to label Fos was performed as previously described. Brain sections were then incubated overnight with the primary antibody anti-5-HT (1:10,000; Immunostar, Hudson, WI, USA). The sections were subsequently incubated for 60 min with a solution containing a biotinylated secondary antibody made in donkey (1:1000) followed by 60 min in the ABC complex (1:5000). Sections were subjected to the DAB reaction without nickel sulfate. Therefore, while Fos produced black nuclear staining, the 5-HT reaction resulted in a brownish cytoplasmic staining. The sections were then mounted onto gelatin-coated slides with a coverslip using DPX (Sigma Chemical, St. Louis, MO, USA).
Image collection and data analysis
The sections were analyzed using bright field illumination on an optical microscope (Olympus BX41) coupled with a camera (Q-imaging Olympus). Three representative sections of each Table 6 The behavioral categories used for behavioral analysis. Based on Halford et al. (1998 (Paxinos and Watson, 2007) . In the hypothalamus we counted the number of Fos positive neurons in the paraventricular nucleus (PVN), ventromedial nucleus (VMH), arcuate nucleus (ARC) and lateral hypothalamic area (LHA). For this analysis, we used the following levels: Bregma À1.32 mm to Bregma À1.92 mm for PVN and LHA, Bregma À2.04 to Bregma À3.00 mm for VMH and Bregma À1.92 to À3.60 for ARC. Only cells exhibiting a dark/black nuclear staining were considered in the counting. Photoshop (Adobe) image-editing software was used to combine photomicrographs into plates and adjust of sharpness, contrast, and brightness.
Statistical analysis
The dose/response curves of ingestive and non-ingestive behaviors were analyzed by the one-way ANOVA followed by Duncan's post hoc analysis. For the immunohistochemistry groups, the data relating to non-ingestive behaviors were analyzed by the twoway ANOVA followed by Duncan's post hoc analysis using treatments (Vehicle and Adrenaline) and access to food during the behavior recording (Access to Food group -AF group; Without Access to Food group -WAF group) as factors. The number of labeled cells per nuclei was analyzed separately, first by the Kolmogorov-Smirnov test to assess normality, then by the twoway ANOVA followed by Duncan's post hoc analysis, using treatments (Vehicle and Adrenaline) and access to food during the behavior recording (Access to Food group -AF group; Without Access to Food group -WAF group) as factors. In all statistical analysis only p values <.05 were accepted as statistically significant. The statistical analysis was performed with the Statistica 8.0 software (STATSOFT, Tulsa, OK, USA).
